Two new mouse models of uterine cancer shed light on how this disease—the most common gynecological cancer in the U.S. - happens. Led by researchers at Baylor College of Medicine, the team of scientists found that the Transforming ...
Jan 15, 2019
0
22
(HealthDay)—"Dry January" is the self-improvement meme of the moment, with people around the world pledging to take a break from alcohol this month.
Jan 3, 2019
0
15
Scientists have identified a growth factor found in the kidneys that could minimise the diabetes-inducing effects of blood vessel damage.
Dec 21, 2018
0
113
A novel way in which the inflammatory response to pain is regulated has been described in the open-access journal eLife.
Dec 18, 2018
0
3
An Osaka University-led research team has developed a system for simply and efficiently producing human norovirus. By coaxing human induced pluripotent stem cells (iPSCs) to develop into a type of cell that usually lines ...
Dec 11, 2018
0
0
Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small ...
Dec 10, 2018
0
155
Osteoarthritis, a disease that causes severe joint pain, affects more than 20 million people in the United States. Some drug treatments can help alleviate the pain, but there are no treatments that can reverse or slow the ...
Nov 28, 2018
3
407
Cell-penetrating peptides (CPPs) have attracted great interest as delivery vehicles in medicine, with potential for the development of novel therapeutic agents or cosmetic products. Biological membranes are typically impermeable ...
Researchers at Utah State University have developed new devices to mechanically stress human cells in the lab.
Oct 24, 2018
0
8
A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in opthalmology, to treat uveítis, thus stopping the inflammation from spreading.
Oct 22, 2018
0
1
